Suchergebnisse - "Magro, F"

PubPharm (150)

11

Editorial : ulcerative colitis submucosal fibrosis and inflammation: more than just strictures

enthalten in: Alimentary pharmacology & therapeutics | 2018

von Magro, F. | Sousa, H.

CommentOn: Aliment Pharmacol Ther. 2018 Apr;47(7):922-939. - PMID 29411405

12

Long-Term Safety of In Utero Exposure to Anti-TNFα Drugs for the Treatment of Inflammatory Bowel Disease : Results from the Multicenter European TEDDY Study

enthalten in: The American journal of gastroenterology | 2018

von Chaparro, M. | Verreth, A. | Lobaton, T. | +61

CommentIn: Am J Gastroenterol. 2018 Dec;113(12):1903. - PMID 29895982

13

The performance of Remicade®-optimized quantification assays in the assessment of Flixabi® levels

enthalten in: Therapeutic advances in gastroenterology | 2018

von Magro, F. | Rocha, C. | Vieira, A. | +6

14

Antigenic response to CT‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

enthalten in: Alimentary Pharmacology & Therapeutics | 2018

von Goncalves, J. | Santos, M. | Acurcio, R. | +29

15

Editorial : antigenic response to CT‐P13 and infliximab originator in IBD shows similar epitope recognition—evidence from basic science supports safe switching to biosimilars. Authors’ reply

enthalten in: Alimentary Pharmacology & Therapeutics | 2018

von Goncalves, J. | Magro, F. | Danese, S. | +2

16

Levels of 6-thioguanine nucleotides and clinical remission in inflammatory bowel disease - A systematic review and meta-analysis : PS083

enthalten in: Porto biomedical journal | 2017

von Estevinho, M. | Afonso, J. | Rosa, I. | +5

17

Proactive therapeutic drug monitoring of infliximab : a comparative study of a new point-of-care quantitative test with two established ELISA assays

enthalten in: Alimentary pharmacology & therapeutics | 2016

von Afonso, J. | Lopes, S. | Gonçalves, R. | +11

18

Reintroduction of Anti-TNFα Therapy After (or even During) Anti-TNFα-associated Tuberculosis in Immune-mediated Diseases

enthalten in: Journal of Crohn's & colitis | 2016

von Abreu, C. | Sarmento, A. | Magro, F.

19

Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays

enthalten in: Therapeutic advances in gastroenterology | 2016

von Afonso, J. | Lopes, S. | Goncalves, R. | +21

20

Proactive therapeutic drug monitoring of infliximab: a comparative study of a new point‐of‐care quantitative test with two established ELISA assays

enthalten in: Alimentary pharmacology & therapeutics | 2016

von Afonso, J. | Lopes, S. | Gonçalves, R. | +10